Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · IEX Real-Time Price · USD
1.270
-0.010 (-0.78%)
At close: Jul 19, 2024, 4:00 PM
1.300
+0.030 (2.36%)
Pre-market: Jul 20, 2024, 9:28 AM EDT
CNTB Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for CNTB stock have an average target of 6.50, with a low estimate of 5.00 and a high estimate of 8.00. The average target predicts an increase of 411.81% from the current stock price of 1.27.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jun 13, 2024.
Analyst Ratings
The average analyst rating for CNTB stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +529.92% | Jun 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $7 → $8 | Strong Buy | Maintains | $7 → $8 | +529.92% | Apr 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $7 | Strong Buy | Initiates | $7 | +451.18% | Mar 4, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $5 | Buy | Reiterates | $5 | +293.70% | Sep 13, 2023 |
| SVB Leerink | SVB Leerink | Buy Maintains $9 → $7 | Buy | Maintains | $9 → $7 | +451.18% | Feb 8, 2023 |
Financial Forecast
Revenue This Year
1.17B
Revenue Next Year
366.26M
from 1.17B
Decreased by -68.56%
EPS This Year
12.03
from -1.08
EPS Next Year
-5.24
from 12.03
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 1.2B | 377.0M | 391.4M | 638.3M | 559.8M |
| Avg | 1.2B | 366.3M | 380.2M | 347.0M | 417.4M |
| Low | 1.1B | 351.9M | 365.3M | 71.1M | 279.5M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | -67.6% | 6.9% | 67.9% | 61.3% |
| Avg | - | -68.6% | 3.8% | -8.7% | 20.3% |
| Low | - | -69.8% | -0.3% | -81.3% | -19.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 12.39 | -5.40 | -3.19 | -0.08 | -1.22 |
| Avg | 12.03 | -5.24 | -3.10 | -0.07 | -1.18 |
| Low | 11.56 | -5.04 | -2.98 | -0.07 | -1.14 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.